Reference data : LOINC code

Filter

Filter on:	In :	Clear filter

Filter on:	In :

Filter on:	In :

Results

Loinc Number	Component	Property	System	Time aspect	ScaleType	MethodType	loincStatus	Long Common name	chngType	DefinitionDescription	exampleUnits	exmplAnswers	loincClass	loincNum	methodTyp	orderObs	shortName	unitsRequired	relatedNames2	VersionLastChanged	VersionFirstRelease	STATUS_REASON	COMMON_TEST_RANK
41275-9	Amino acids intense band position	Prid	Urine	Pt	Nom		ACTIVE	Amino acids intense band position [Identifier] in Urine	MIN	DefinitionDescription			CHEM	41275-9		Observation	Amino acids intense band position Ur	N	AA; Acd; Acid; Amino acid; Amino acids.total; Bands; bnd; Chemistry; Identity or presence; Nominal; Point in time; Random; UA; UR; Urn	2.21	2.15
41276-7	Anion gap	SCnc	Bld	Pt	Qn	Calculated	ACTIVE	Anion gap in Blood by calculation	MAJ	DefinitionDescription	mmol/L		CHEM	41276-7	Calculated	Observation	Anion Gap Bld Calc-sCnc	N	Ag; AnGAP; Blood; Calc; Calculation; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	2.79	2.15	mmol/L
41277-5	Gross blood	PrThr	Body fld	Pt	Ord		ACTIVE	Gross blood [Presence] of Body fluid Qualitative	MIN	DefinitionDescription		Present/Absent	SPEC	41277-5		Observation	Gross Blood Fld Ql	N	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SPEC	2.56	2.15		The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.
41278-3	Gross blood	PrThr	Stool	Pt	Ord		ACTIVE	Gross blood [Presence] of Stool Qualitative	MIN	DefinitionDescription		Blood visually noted	SPEC	41278-3		Observation	Gross Blood Stl Ql	N	Bowel movement; Faecal; Faeces; Fecal; Feces; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SPEC; Stl; Stool = Fecal	2.73	2.15		The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.
41279-1	Borrelia burgdorferi Ab.IgG/Borrelia burgdorferi Ab.IgM	Ratio	Ser	Pt	Qn		ACTIVE	Borrelia burgdorferi IgG Ab/IgM Ab [Ratio] in Serum	MIN	DefinitionDescription	Index		MICRO	41279-1		Observation	B burgdor IgG/IgM Ser-Rto	N	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Lyme; Lyme disease; Lymes; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Serum; SR	2.73	2.15	{Index_val}
4128-5	Anileridine	Mass	Dose	Pt	Qn		ACTIVE	Anileridine [Mass] of Dose	MIN	DefinitionDescription			DRUGDOSE	4128-5		Observation	Anileridine Dose	Y	Dose med or substance; DRUG DOSES; Leritine; Point in time; QNT; Quan; Quant; Quantitative; Random	2.69	1	mg
41280-9	Observation	Aper	Synv fld.spun	Pt	Nom		ACTIVE	Appearance of Spun Synovial fluid	NAM	DefinitionDescription			SPEC	41280-9		Observation	Appearance spun Snv	N	Appearance; Joint aspirate; Joint fld; Joint flu; Joint fluid; Nominal; Point in time; Random; SF; SNV; SPEC; spun Snv; Supernat; Supernate; Syn; Syn fl; Synov; Synovial fluid	2.79	2.15		Release 2.79: COMPONENT: Triggered by coll w SCT: component that the description is property like as in Color, Appearance, Osmolality have changed to Component: Observation, and Property: Color, or Appearance, or Osmolality, so forthÃ¢â?¬Â¦;
41281-7	Burr cells	NCnc	CSF	Pt	Qn	Manual count	ACTIVE	Burr cells [#/volume] in Cerebral spinal fluid by Manual count	MIN	DefinitionDescription	10*6/L		HEM/BC	41281-7	Manual count	Observation	Burr Cells # CSF Manual	N	#; ABS; absolute; absolutes; Cell; Cellularity; Cerebral spinal fluid; Cerebrospinal Fl; Cnt; Count; Count/volume; CT; Echinocyte; Echinocytes; Erythrocytes.crenated; HEMATOLOGY/CELL COUNTS; Manl; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Sea urchin cells; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	2.7	2.15	/uL
41282-5	Erythrocytes.nucleated/Leukocytes	Ratio	Body fld	Pt	Qn	Manual count	ACTIVE	Nucleated erythrocytes/Leukocytes [Ratio] in Body fluid by Manual count	NAM	DefinitionDescription	%		HEM/BC	41282-5	Manual count	Observation	nRBC Fld Manual-Rto	N	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Discocytes; Erthrocyte; Erythroblasts; Erythrocyte; Fl; Fld; FLU; Fluid; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Normoblasts; nRBC; nRBCs; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Rto; WBC; WBCs; White blood cell; White blood cells	2.79	2.15	/100{WBCs}	Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component;
41283-3	HLA-DQ8	PrThr	Bld/Tiss	Pt	Ord		ACTIVE	HLA-DQ8 [Presence]	MIN	DefinitionDescription			HLA	41283-3		Observation	HLA-DQ8 Ql	N	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	2.73	2.15		This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.
41284-1	Epithelial cells.non-squamous	Naric	Urine sed	Pt	Qn	Microscopy.light.HPF	ACTIVE	Epithelial cells.non-squamous [#/area] in Urine sediment by Microscopy high power field	MIN	DefinitionDescription	/HPF		UA	41284-1	Microscopy.light.HPF	Observation	Non-sq Epi Cells #/area UrnS HPF	N	#/area; Cell; Cellularity; Epi; Epi Cells; Epith; Epithelia; Kidney; LM; Micro; Micros; Microscopic; Nephrology; Non-sq Epi Cells; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; Renal; Round epithelial cells; Small epithelial cells; Sq; UA; UR; URINALYSIS; Urine sediment; Urn; UrnS	2.73	2.15	/[HPF]
41285-8	Uranium.depleted/Creatinine	MRto	Urine	24H	Qn		ACTIVE	Uranium depleted/Creatinine [Mass Ratio] in 24 hour Urine	MIN	DefinitionDescription	ug/g creatinine		DRUG/TOX	41285-8		Both	Depleted U/Creat 24h Ur	N	1 day; 24 hours; 24HR; CR; Crea; Creat; Depleted U; DRUG/TOXICOLOGY; Drugs; Du; Mass concentration ratio; Mass ratio; MCRto; QNT; Quan; Quant; Quantitative; U; UA; UCr; UR; Urn	2.7	2.15	ug/g{creat}
41286-6	Uranium 235/Uranium 238	MRto	Urine	Pt	Qn		ACTIVE	Uranium 235/Uranium 238 [Mass Ratio] in Urine	MIN	DefinitionDescription			DRUG/TOX	41286-6		Both	Uranium 235/Uranium 238 Ur	N	DRUG/TOXICOLOGY; Drugs; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; U; UA; UR; Urn	2.42	2.15
41287-4	Epithelial cells.parabasal	PrThr	Vag	Pt	Ord	Microscopy.light	ACTIVE	Epithelial cells.parabasal [Presence] in Vaginal fluid by Light microscopy	MIN	DefinitionDescription			HEM/BC	41287-4	Microscopy.light	Observation	Parabasal Cells Vag Ql Micro	N	Cell; Cellularity; Epi; Epi Cells; Epith; Epithelia; Genital vaginal; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Ordinal; Parabasal Cells; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Vag fld; Vag fluid; Vagina; Vaginal fluid	2.56	2.15		The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.
41288-2	Egg whole Ab.IgE/IgE.total	AFr	Ser	Pt	Qn		ACTIVE	Whole Egg IgE Ab/IgE total in Serum	MIN	DefinitionDescription	% response		ALLERGY	41288-2		Both	Whole Egg IgE/IgE total %	N	%; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; f245; IgE total; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Tot; Total IgE; Totl; Whole Egg; Yolk+White	2.7	2.15	%{response}	The divisor /IgE.total has been added to this term to clarify that the denominator is the patient's total IgE, and Property has been corrected from Ratio to AFr.
41289-0	11-Deoxycortisol^post dose metyraPONE	MCnc	Ser/Plas	Pt	Qn		ACTIVE	11-Deoxycortisol [Mass/volume] in Serum or Plasma --post dose metyraPONE	MIN	DefinitionDescription	ug/dL		CHAL	41289-0		Observation	11DC p metyraPONE SerPl-mCnc	N	11DC; After; CHEMISTRY.CHALLENGE TESTING; Compound S; Cortexolone; Cortodoxone; Deoxycortisol; Desoxycortisol; Level; Mass concentration; Metopirone; p dose; p metyraPONE; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	2.73	2.15	ug/dL
4129-3	Anthraquinone	Mass	Dose	Pt	Qn		ACTIVE	Anthraquinone [Mass] of Dose	MIN	DefinitionDescription			DRUGDOSE	4129-3		Observation	Anthraquinone Dose	Y	Athracenedione; Dioxoanthracene; Dose med or substance; DRUG DOSES; Point in time; QNT; Quan; Quant; Quantitative; Random	2.69	1	mg
41290-8	HIV 1+2 Ab.IgM	ACnc	Ser/Plas	Pt	Qn	IA	ACTIVE	HIV 1+2 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay	MIN	DefinitionDescription	OD ratio	1.5	MICRO	41290-8	IA	Both	HIV1+2 IgM SerPl IA-aCnc	N	ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HIV 1 & 2; HIV 1 and 2 Ab; HIV type 1; HIV type I; HIV1; HIV1+2; Human immunodeficiency virus; i; IAA; ID; II; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	2.73	2.16	{OD_ratio}	Updated system from Ser to Ser/Plas; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016.
41291-6	Immunization	Hx	^Patient	Pt	Nom		ACTIVE	History of Immunization	NAM	DefinitionDescription			H&P.HX	41291-6			Hx of Immunization	N	H+P; H+P.HX; History; Immunization status; Nominal; P prime; Point in time; Random; Vaccination; Vaccinations; Vaccine	2.56	2.16		Changed Component from "History of immunizations" to "Immunization", Property from "Find" to "Hx" and removed Method of "Reported" per 8/2015 Clinical LOINC Committee decision
41292-4	Soluble mesothelin related proteins	SCnc	Ser/Plas	Pt	Qn		ACTIVE	Soluble mesothelin related proteins [Moles/volume] in Serum or Plasma	MIN	DefinitionDescription	nmol/L	SMRP 4.6 nmol/L (UPTO 1.5)	CHEM	41292-4		Both	SMRP SerPl-sCnc	N	Chemistry; Level; Mesothelioma; Pl; Plasma; Plsm; Point in time; Protein; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SMRP; SR; Substance concentration; Tumor marker	2.73	2.16	nmol/L
41293-2	Clot	Arb	XXX	Pt	Ord		ACTIVE	Clotted specimen	MIN	DefinitionDescription		Present/Absent	SPEC	41293-2		Observation	Clot Spec Ql	N	Arbitrary; Misc; Miscellaneous; Ordinal; Other; Point in time; QL; Qual; Qualitative; Random; Screen; SPEC; To be specified in another part of the message; Unspecified	2.73	2.16
41294-0	Cells.S phase	PrThr	XXX	Pt	Ord		ACTIVE	S-phase cells [Presence] in Specimen	MIN	DefinitionDescription		High/Low/Moderate	MOLPATH	41294-0		Observation	S Phs Cells Spec Ql	N	Cell; Cell proliferative activity; Cellularity; Misc; Miscellaneous; Molecular pathology; MOLPATH; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; S Phs Cells; S prime; Screen; Spec; To be specified in another part of the message; Unspecified	2.69	2.16		The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.
41295-7	Flexion.active range of motion	Angle	Shoulder.left	Pt	Qn		ACTIVE	Shoulder - left Flexion Active Range of Motion Quantitative	MIN	DefinitionDescription	deg		H&P.PX	41295-7		Both	Should-L Flx AROM Qn	N	AROM; Flx AROM; H+P; H+P.PX; L; LT; MSK; Musculoskeletal; Ortho; Orthopedics; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Rnge; Should-L; Upper extremity joint	2.48	2.16	deg
41296-5	Flexion.passive range of motion	Angle	Shoulder.left	Pt	Qn		ACTIVE	Shoulder - left Flexion Passive Range of Motion Quantitative	MIN	DefinitionDescription	deg		H&P.PX	41296-5		Both	Should-L Flx PROM Qn	N	Flx PROM; H+P; H+P.PX; L; LT; MSK; Musculoskeletal; Ortho; Orthopedics; P prime; Point in time; PROM; QNT; Quan; Quant; Quantitative; Random; Rnge; Should-L; Upper extremity joint	2.48	2.16	deg
41297-3	Extension.active range of motion	Angle	Shoulder.left	Pt	Qn		ACTIVE	Shoulder - left Extension Active Range of Motion Quantitative	MIN	DefinitionDescription	deg		H&P.PX	41297-3		Both	Should-L Ext AROM Qn	N	AROM; EXT; Ext AROM; H+P; H+P.PX; L; LT; MSK; Musculoskeletal; Ortho; Orthopedics; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Rnge; Should-L; Upper extremity joint	2.48	2.16	deg